Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pabst

Showing results (211-220 of 332) with videos related to

Pageof 34
Sort By:
American Journal of Hematology|September 30, 2017
Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remissionNorbert-Claude Gorin, Myriam Labopin, Thomas Pabst, et al.
EJNMMI Physics|April 13, 2026
Contrast-enhanced CT for attenuation correction in ultra-high sensitivity long-axial field-of-view lymphoma PET: amplified quantification problems?Jan-Luca Penner, August Blomgren, Alexander Weissensee, et al.
Swiss Medical Weekly|May 23, 2015
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2020
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose ChemotherapyPaul J Bröckelmann, Horst Müller, Teresa Guhl, et al.
Experimental Hematology|July 17, 2020
Analysis of IL-6 serum levels and CAR T cell-specific digital PCR in the context of cytokine release syndromeThomas Pabst, Raphael Joncourt, Evgenii Shumilov, et al.
Swiss Medical Weekly|April 4, 2019
Updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
The Lancet. Haematology|October 7, 2018
Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trialsBastian von Tresckow, Stefanie Kreissl, Helen Goergen, et al.
Bone Marrow Transplantation|November 14, 2021
Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantationEvgenii Shumilov, Inna Shakhanova, Johanna Flach, et al.
Eclinicalmedicine|November 29, 2023
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trialFelix Keil, Antonia M S Müller, Andrea Berghold, et al.
Haematologica|October 21, 2017
Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trialsRichard F Schlenk, Jürgen Krauter, Emmanuel Raffoux, et al.
Pageof 34

Showing results (211-220 of 332) with videos related to

Sort By:
Pageof 34
American Journal of Hematology|September 30, 2017
Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remissionNorbert-Claude Gorin, Myriam Labopin, Thomas Pabst, et al.
EJNMMI Physics|April 13, 2026
Contrast-enhanced CT for attenuation correction in ultra-high sensitivity long-axial field-of-view lymphoma PET: amplified quantification problems?Jan-Luca Penner, August Blomgren, Alexander Weissensee, et al.
Swiss Medical Weekly|May 23, 2015
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2020
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose ChemotherapyPaul J Bröckelmann, Horst Müller, Teresa Guhl, et al.
Experimental Hematology|July 17, 2020
Analysis of IL-6 serum levels and CAR T cell-specific digital PCR in the context of cytokine release syndromeThomas Pabst, Raphael Joncourt, Evgenii Shumilov, et al.
Swiss Medical Weekly|April 4, 2019
Updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
The Lancet. Haematology|October 7, 2018
Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trialsBastian von Tresckow, Stefanie Kreissl, Helen Goergen, et al.
Bone Marrow Transplantation|November 14, 2021
Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantationEvgenii Shumilov, Inna Shakhanova, Johanna Flach, et al.
Eclinicalmedicine|November 29, 2023
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trialFelix Keil, Antonia M S Müller, Andrea Berghold, et al.
Haematologica|October 21, 2017
Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trialsRichard F Schlenk, Jürgen Krauter, Emmanuel Raffoux, et al.
Pageof 34